Suppr超能文献

一项基于急诊科的同伴康复支持干预的随机临床试验,旨在增加高危阿片类药物过量人群的治疗参与度并减少复发性过量用药:导航者试验研究方案。

Randomised clinical trial of an emergency department-based peer recovery support intervention to increase treatment uptake and reduce recurrent overdose among individuals at high risk for opioid overdose: study protocol for the navigator trial.

机构信息

Department of Epidemiology, Brown University School of Public Health, Providence, Rhode Island, USA.

Department of Emergency Medicine, Brown University Warren Alpert Medical School, Providence, Rhode Island, USA.

出版信息

BMJ Open. 2019 Nov 11;9(11):e032052. doi: 10.1136/bmjopen-2019-032052.

Abstract

INTRODUCTION

Effective approaches to increase engagement in treatment for opioid use disorder (OUD) and reduce the risk of recurrent overdose and death following emergency department (ED) presentation for opioid overdose remain unknown. As such, we aim to compare the effectiveness of behavioural interventions delivered in the ED by certified peer recovery support specialists relative to those delivered by licensed clinical social workers (LCSWs) in promoting OUD treatment uptake and reducing recurrent ED visits for opioid overdose.

METHODS AND ANALYSIS

Adult ED patients who are at high risk for opioid overdose (ie, are being treated for an opioid overdose or identified by the treating physician as having OUD) (n=650) will be recruited from two EDs in a single healthcare system in Providence, Rhode Island into a two-arm randomised trial with 18 months of follow-up postrandomisation. Eligible participants will be randomly assigned (1:1) in the ED to receive a behavioural intervention from a certified peer recovery support specialist or a behavioural intervention from an LCSW. The primary outcomes are engagement in formal OUD treatment within 30 days of the initial ED visit and recurrent ED visits for opioid overdose within 18 months of the initial ED visit, as measured through statewide administrative records.

ETHICS AND DISSEMINATION

This protocol was approved by the Rhode Island Hospital institutional review board (Approval Number: 212418). Data will be presented at national and international conferences and published in peer-reviewed journals.

TRIAL REGISTRATION NUMBER

NCT03684681.

摘要

简介

目前仍缺乏有效的方法来提高阿片类药物使用障碍(OUD)的治疗参与度,降低急诊就诊后阿片类药物过量复发和死亡的风险。因此,我们旨在比较由经过认证的同伴康复支持专家在急诊室提供的行为干预措施与由持照临床社会工作者(LCSW)提供的行为干预措施在促进 OUD 治疗参与度和减少阿片类药物过量复发急诊就诊方面的有效性。

方法和分析

从罗德岛普罗维登斯市的两家急诊室招募 650 名处于阿片类药物过量高风险的成年急诊患者(即正在接受阿片类药物过量治疗或被主治医生认定为患有 OUD),将其纳入一项为期 18 个月的随访的双臂随机试验。符合条件的参与者将在急诊室随机(1:1)分配接受经过认证的同伴康复支持专家提供的行为干预或由 LCSW 提供的行为干预。主要结局是在初始急诊就诊后 30 天内接受正式 OUD 治疗的比例和在初始急诊就诊后 18 个月内阿片类药物过量复发急诊就诊的比例,通过全州行政记录进行测量。

伦理和传播

该方案已获得罗德岛医院机构审查委员会的批准(批准号:212418)。数据将在国家和国际会议上展示,并发表在同行评议的期刊上。

试验注册号

NCT03684681。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd7e/6858243/ac74635d7b2c/bmjopen-2019-032052f01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验